The Pulse by Wharton Digital Health

Our guest on this episode is Nawal Roy. Nawal Roy is the founder and CEO of Holmusk, a company that specializes in real-world evidence, AI-powered analytics, and digital solutions to solve the evidence gaps problem in mental health.

Last year, Holmusk raised a series B funding round of $45M, led by Veradigm, a leading provider of healthcare data and technology solutions. Powered by this investment, Holmusk’s NeuroBlu database recently reached a pivotal milestone of 4 million patient lives, becoming the largest NLP-enriched, de-identified real-world data platform designed for behavioral health and mental health research.

Nawal and I discussed:

• Holmusk’s founding story, how Nawal connected his background and skill sets in finance to healthcare, and where he saw opportunities in building a “Bloomberg Terminal” for behavioral health
• Holmusk’s flagship platform, Neuroblu, which organizes and analyzes a large volume of real-world data to provide insights for research, care improvement, and marketing purposes
• Generative AI and natural language processing (NLP) and their the potential to revolutionize mental health care by enabling precision psychiatry, improving the standardization of treatment protocols, and bridging the evidence gap
• Holmusk’s active partnerships with healthcare systems, pharma companies, and government organizations to expand its data set and drive meaningful change in the industry

Our guest on this episode is Todd Park. Todd is the co-founder and Executive Chairman of Devoted Health, a Medicare Advantage “payvider” providing virtual and in-home medical care for older Americans and leveraging their technology platform to drive clinical results. Founded in 2017, Devoted’s team of over 2,000 cares for nearly 124,000 members across 14 states. Todd previously served as the White House Technology Advisor and the HHS Chief Technology Officer in the Obama Administration, and was the co-founder of athenahealth and Castlight.

In this episode, I spoke with Todd about

• His entrepreneurial journey
• His time in the White House
• Why Devoted is situated to transform the healthcare experience for older Americans

In this episode of The Pulse, I sat down with Dr. Adam Wolfberg, Chief Medical Officer of Virta Health, a company pioneering a new approach to tackling metabolic disease.

Virta Health has a mission to reverse type 2 diabetes and obesity through nutrition-first treatment and tech-enabled care. We discussed Adam’s unconventional journey from news reporter to startup exec, Virta’s science-backed outcomes, and why GLP-1s aren’t the only answer to America’s weight crisis.

Our guest on this episode is ⁠Jim Pursley⁠, President of ⁠Hinge Health⁠. Founded in 2014, Hinge Health is revolutionizing musculoskeletal (MSK) care by combining virtual physical therapy, wearable technology, and multidisciplinary care teams. Through AI-powered motion tracking, real-time exercise guidance, and personalized health coaching, Hinge Health is improving outcomes for patients while reducing healthcare costs.

In the episode, Jim and I discussed: 1) The founding story of Hinge Health and key moments shaping its mission, 2) How Hinge Health integrates AI, motion tracking, and Enso technology to deliver remote MSK care, 3) Overcoming skepticism around virtual physical therapy and the challenges of scaling in a complex healthcare ecosystem, and 4) The future of healthcare innovation, including unified care models and AI-driven advancements

In this episode, I sat down with Belinda Tan and Noah Craft, Co-Founders and Co-CEOs at People Science. Founded in 2019, People Science is a human-centered clinical research platform addressing the need for rigorous clinical science to back alternative medicines and wellness solutions that do not typically fall under traditional Western medicine. The company’s platform studies a range of solutions spanning microbiome and food-as-medicine interventions, natural and synthetic psychedelic medicines, cannabis and cannabinoids, functional medicines, and digital therapeutics. Its user-facing app called Chloe (Consumer Health Learning and Organizing Ecosystem) supports users to test these alternative treatments on themselves, and enables users to view personal results in real time while comparing themselves to others. People Science secured its $8.5 million seed funding through two rounds, most recently in December 2022.

Belinda, Noah and I discussed: 1) Their founding story and unique co-CEO leadership model, 2) The philosophy behind the People Science platform, including the nuances of alternative medicines compared to traditional Western medicine, 3) The business model, including both how studies are launched with B2B partners and the consumer-facing app (Chloe), and 4) Insights and advice from having co-founded and co-led not one, but two, companies together.